Eternal founder Deepinder Goyal has defended Temple, his wearable, after days of backlash. He says it targets a global market, with India expected to make up no more than 1% of sales.
Doctors have questioned the device's brain health claims. Goyal responded that Temple is a fitness and AI gadget, not a medical product, and that it has not been proven to diagnose or prevent any disease.
He plans to publish a note on Monday, November 9, explaining how Temple calculates Brain Flow and where its limits lie. Claims that need regulatory approval will wait until that approval is secured.
